MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
3.349
+0.029
+0.87%
Opening 10:51 05/19 EDT
OPEN
3.150
PREV CLOSE
3.320
HIGH
3.349
LOW
3.150
VOLUME
24.96K
TURNOVER
--
52 WEEK HIGH
6.80
52 WEEK LOW
2.550
MARKET CAP
36.12M
P/E (TTM)
-1.8151
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LTRN last week (0512-0516)?
Weekly Report · 3h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2d ago
Lantern Pharma management to meet virtually with Lake Street
TipRanks · 2d ago
Lantern Pharma Advances AI-Driven Cancer Therapies
TipRanks · 3d ago
Lantern Pharma’s Earnings Call: Progress and Prospects
TipRanks · 3d ago
Lantern Pharma outlines commercialization of radar AI modules and expects LP-184 trial enrollment completion by June 2025
Seeking Alpha · 3d ago
Lantern Pharma Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 4d ago
Lantern Pharma GAAP EPS of -$0.42 beats by $0.07
Seeking Alpha · 4d ago
More
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.